Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women
European Journal of Clinical Investigation Feb 12, 2019
Chen P, et al. - In a population-based cohort study, researchers analyzed the relationship between nonalcoholic fatty liver disease (NAFLD) and free triiodothyronine (FT3) in euthyroid subjects. A total of 3144 euthyroid subjects were selected for cross-sectional analysis in the baseline of the Shanghai Nicheng Atherosclerosis Study, and 2089 subjects were selected for longitudinal analysis after 2.2 years. They observed that FT3 levels increased with the occurrence of NAFLD and decreased with the remission of NAFLD in euthyroid women after a 2.2-year follow-up. In euthyroid women, there are positive associations of FT3 levels with NAFLD and the risk of NAFLD progression. Changes in FT3 levels with changes in the status of NAFLD can be an adaptive response to maintain energy and metabolic homeostasis.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries